A
Akari Therapeutics (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD0.95
- USD0.96
- USD0.91
- USD4.40
- -21.80%
- --
- 12.00k
- 25.19k
- 23M
- 0.85
- -56.50%
Stock News
yesterday
Jim Cramer: The White House should change its messaging
CNBC
yesterday
What happens to gift cards when a chain like Joann or Dollar General closes stores? Here’s what shoppers can do.
MarketWatch
yesterday
Almonds, whiskey, auto parts: EU's retaliatory tariffs set up these U.S. states and local products as the biggest losers
CNBC
yesterday
Comcast expands partnership with Olympics, extends media rights through 2036
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
